Literature DB >> 2014979

Structure-activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose.

I Gruda1, D Milette, M Brother, G S Kobayashi, G Medoff, J Brajtburg.   

Abstract

The effects of four monoesters of sucrose with different acyl chain lengths (palmitate, C16; myristate, C14; laurate, C12; and caprate, C10) on the aggregation state of amphotericin B (AmB), its binding to cholesterol and ergosterol, its toxicity to cells, and its lethality to mice were determined. In solution, all four of these esters inhibited AmB binding to cholesterol more than to ergosterol; this effect correlated with the ester-induced shift from the mainly aggregated form of AmB to the mainly monomeric form. In experiments with cells, the esters inhibited the toxicity of AmB to mouse erythrocytes and cultured mouse fibroblast L-929 cells more than its toxicity to Candida albicans cells. When injected intravenously with AmB, these esters decreased AmB lethality to mice. In all of these assays, the ester with the shortest chain length (caprate) was much less potent than the other three esters. Our results indicate a correlation between in vitro and in vivo assays and suggest that the in vitro and in vivo selectivity of AmB may be enhanced by surface-active agents which modulate the aggregation state of AmB.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014979      PMCID: PMC244936          DOI: 10.1128/AAC.35.1.24

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Polydispersity of aggregates formed by the polyene antibiotic amphotericin B and deoxycholate. A spin label study.

Authors:  M T Lamy-Freund; V F Ferreira; S Schreier
Journal:  Biochim Biophys Acta       Date:  1989-06-06

Review 2.  Lipid emulsions as drug delivery systems.

Authors:  S S Davis; C Washington; P West; L Illum; G Liversidge; L Sternson; R Kirsh
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

3.  Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations.

Authors:  S Jullien; J Brajtburg; J Bolard
Journal:  Biochim Biophys Acta       Date:  1990-01-15

4.  Biological effects of surfactants, IV. Effects of non-ionics and amphoterics on HeLa cells.

Authors:  R Ernst; J Arditti
Journal:  Toxicology       Date:  1980       Impact factor: 4.221

Review 5.  How do the polyene macrolide antibiotics affect the cellular membrane properties?

Authors:  J Bolard
Journal:  Biochim Biophys Acta       Date:  1986-12-22

6.  Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells.

Authors:  R Mehta; G Lopez-Berestein; R Hopfer; K Mills; R L Juliano
Journal:  Biochim Biophys Acta       Date:  1984-03-14

7.  Unusual lipid structures selectively reduce the toxicity of amphotericin B.

Authors:  A S Janoff; L T Boni; M C Popescu; S R Minchey; P R Cullis; T D Madden; T Taraschi; S M Gruner; E Shyamsunder; M W Tate
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.

Authors:  T F Patterson; P Miniter; J Dijkstra; F C Szoka; J L Ryan; V T Andriole
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

9.  Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.

Authors:  F C Szoka; D Milholland; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Effect of the aggregation state of amphotericin B on its interaction with ergosterol.

Authors:  I Gruda; N Dussault
Journal:  Biochem Cell Biol       Date:  1988-03       Impact factor: 3.626

View more
  6 in total

1.  Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.

Authors:  Samusi A Adediran; Timothy P Day; Diptesh Sil; Matthew R Kimbrell; Hemamali J Warshakoon; Subbalakshmi S Malladi; Sunil A David
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 2.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation.

Authors:  Celeste Alvarez; David R Andes; Jeong Yeon Kang; Carmen Krug; Glen S Kwon
Journal:  Pharm Res       Date:  2017-02-15       Impact factor: 4.200

4.  Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.

Authors:  Celeste Alvarez; Dae Hwan Shin; Glen S Kwon
Journal:  Pharm Res       Date:  2016-05-19       Impact factor: 4.200

5.  Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.

Authors:  J A Sánchez-Brunete; M A Dea; S Rama; F Bolás; J M Alunda; R Raposo; M T Méndez; S Torrado-Santiago; J J Torrado
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

6.  Significance of algal polymer in designing amphotericin B nanoparticles.

Authors:  Saurabh Bhatia; Vikash Kumar; Kiran Sharma; Kalpana Nagpal; Tanmoy Bera
Journal:  ScientificWorldJournal       Date:  2014-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.